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Abstract
The incidence of inflammatory bowel disease (IBD) is increasing world-wide and 
most patient will require some surgical treatment once in life. IBD surgical patients are 
a challenge to surgeons. Main goals of surgical treatment are (1) to preserve the small 
bowel integrity because many resections may lead the patient to a small bowel short 
syndrome and (2) restore normal function as they have absorption disturbances. IBD 
patients may present mal-nutrition status and/or immunosuppression at the time of 
surgery. Types of surgery range from a simple plasty in Crohn disease to a total procto-
colectomy in Ulcerative Colitis. For Crohn disease most procedures avoid resection and 
use diseased segments to prevent disabsorption. Herein we describe the most currently 
used techniques to treat IBD patients, when to indicate surgery and how to prepare 
them to less outcomes. Patients with Crohn disease with high risk for short bowel syn-
drome and intestinal failure should be submitted to Strictureplasty otherwise, Bowel 
Resection is the favored surgical technique for the management of fibrostenotic. Bowel 
Resection is associated with lower recurrence rate and longer recurrence-free survival.
Keywords: inflammatory bowel disease, strictureplasty, bowel resection, Crohn’s 
disease, ulcerative colitis, surgical outcomes
1. Introduction
1.1 Epidemiology
Many epidemiologic studies report an increase in incidence and prevalence of 
Crohn’s disease [CD] and Ulcerative Colitis (UC) in a global proportion. It is more 
evident in countries that going through an industrialization process, e.g., Asia, South 
America and Middle East [1–3]. The incidence follows the country industrialization 
and people living in urban areas has a greater incidence of IBD [4, 5]. The global 
prevalence of IBD has increased from 79.5 to 84.3 per 100,000 persons in recent 
years. IBD has been considered a disease of high-income regions. The USA had the 
highest age-standardized prevalence rate globally; approximately a quarter of total 
global patients with IBD living there in 2017. The UK had the highest age-standard-
ized prevalence in Europe. The prevalence of IBD range from 252 to 439 cases per 
100 000 population in the USA and 373 per 100 000 population in UK [6].
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1.2 Pathogenesis
The complete mechanism of pathogenesis of IBD still unclear. IBD has a com-
plex immune-mediated inflammatory disease that affects primarily the digestive 
tube. Those individuals with a genetic predisposition when exposed to different 
environmental factors may initiate an inflammatory response that is influenced by 
gut microbiome (Figure 1) [7]. The process is characterized by chronic relapsing 
and remitting inflammation for life.
Many diet components were reported to be protective factors to IBD as fiber, 
short-chain fatty acids, wheat, gluten, zinc, vitamin D. On the other hand some kind 
of food may worsen the disease: FODMAPs, red meat, emulsifiers and sugar [8].
The interaction of diet components with the microbiome is not so simple: more 
fiber, less flares. Some patients complain worsening of symptoms with fibers 
consumption. One hypothesis is that altered microbiome may produce incomplete 
fermentation and then, originating pro-inflammatory byproducts as succinate [9].
The microbiome is the group of all organisms found in the whole gut and 
includes bacteria, fungi, viruses and protozoa. Most of them are found in the colon. 
Many studies showed that IBD patients have altered microbiome and pro-inflam-
matory bacteria. When you treat a patient with Crohn disease and make an ostomy 
avoid intestinal transit in affected bowel segment it result in decreased inflamma-
tion [10–13].
Another evidence of environmental factor is the impairment in Peroxisome 
proliferator-activated receptors-γ (PPARγ) activity. Environmental pollutants can 
block the PPARy signaling pathway while mesalazine enhances its expression [14].
The Hippo pathway is an evolutionarily conserved pathway that controls organ 
size and homoeostasis through modulating cell proliferation, survival, apoptosis, 
and stemness. Hippo pathway is involved in the IBD pathogenesis, including intesti-
nal cell regeneration, gut microbiota, and angio- genesis of the intestines [15, 16].
Crohn disease (CD) and Ulcerative Colitis (UC) are grouped as inflammatory 
bowel diseases but each one has distinct clinical characteristics (Table 1). These 
differences have to be in mind when a bowel resection and anastomosis is done in a 
patient with Crohn disease.
Clinically CD may be classified into three phenotypes: inflammatory, penetrat-
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in the stricturing group and one decade later up to one third of patients may present 
stricturing Figure 2 [18, 19].
The treatment of strictures may be done by endoscopy (endoscopic balloon 
dilatation, strictureplasty or surgical resection of bowel segment.
According to Cosnes et al. [18] the site of lesions is the most important factor to 
determine the disease behavior and progression to complication:
• Small bowel and anoperineal > stricture and penetrating complications;
• Esphagogastroduodenal and colon > inflammation.
In general, 75% of patients with strictures may require surgery once during life-
time but it may range from 70–90%. Right timing in indication of surgery for CD 
Differences Crohn disease Ulcerative colites
Histopathology Full thickness inflammation of bowel 
wall
Compromise mucosa
Organs All gastrointestinal segments;
Generally ilium and colon;
Non-continuous pattern.
Rectum and/or entire colon;
Continuous pattern.
Complications Abscesses, fistulas, strictures. Bleeding, perforation, toxic 
megacolon.
Table 1. 
Characteristics of n disease (CD) and Ulcerative Colites (UC).
Figure 2. 
Natural progression of Crohn disease. (From Jacques Cosnes et al. [18].)
• Refractory to medical therapy
• Fibrostenosing
• Growth retardation
• Fistulizing disease and related complications
• Neoplasia and dysplasia
Table 2. 
Indications for surgery in CD.
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may reduce complication rates, diminish operative technical difficulties and stoma 
indication, less emergency surgeries and also better mortality rates [18, 20, 21].
As CD does not have cure, surgery has a well-defined hole in therapeutic arma-
mentarium. The aim of surgery is to treat complications, control symptoms, to try 
to preserve bowel length and keep to bowel function (Table 2).
2. Preoperative exams
2.1 Endoscopy and enteroscopy
Endoscopy may confirm the IBD diagnosis in most cases up to 90% of patients 
with Crohn disease or Ulcerative colitis. It allows a detailed examination of the 
mucosa of terminal ilium, colon and rectum. It is considered the gold standard 
exam for IBD diagnosis. Enteroscopy is indicated in patients with normal colonos-
copy and gastroscopy but present suspection of Crohn disease. Enteroscpy may be 
diagnostic or therapeutic with dilation of strictures areas (Figure 3) [22].
2.2 Enterography CT and MR
Both radiological methods CT or MR Enterography have been the best non-
invasive exams to evaluate the small bowel in Crohn disease. Enterography may 
identify affected segments, disease activity and complications (abscess and fistula). 
Enterography may help to differentiate inflammatory or fibrotic areas of stenosis 
(Figure 4–6). Stricture is defined as a bowel segment with luminal narrowing and 
unequivocal upstream bowel dilation (Table 3) [23].
Figure 3. 
Enteroscopy showing lesions in the jejunum and normal ileum.
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Figure 4. 
Axial contrast- enhanced CT enterography: homogeneous mural hyperenhancement (long arrow) and 
stratified mural hyperenhacement (short arrow).
Figure 5. 
A – Coronal T2 sequence MR enterography: homogeneous small bowel wall thickening and sacculations 
(arrow); B - Coronal T2 sequence MR enterography: small bowel wall thickening with stratified (bilaminar) 
mural hyperenhancement (arrow).
Figure 6. 
A – Coronal T2 sequence MR enterography: homogeneous small bowel wall thickening (arrow); B - Coronal 
contrast-enhanced fat-suppressed T1-weighted MR enterography: small bowel wall thickening with stratified 
(bilaminar) mural hyperenhancement (arrow).





The primary approach is to resect the small bowel stricture. Resection is associ-
ated to lower rates of recurrence. Patients submitted do strictureplasty alone may 
present a higher rate of disease recurrence [24]. The patient should have a small 
length stricture and no prior resection (Table 4).
Surgery may be done by laparotomy or laparoscopy with same good results and 
2 cm margins of normal tissue is advised to make an anastomosis. Both anastomosis 
may be used: hand-sewn or stapled.
When a ileocolic resection is done the mesentery should be removed. When 
mesentery is left it is associated with higher recurrence rates and  reoperations [25].
3.1.2 Bypass
Bypass surgery has been rarely employed due to the risk of neoplasia in the 
excluded segment [26, 27]. It may be an option to treat duodenal disease. There are 
two types of bypass: simples bypass and exclusion bypass [28]. Exclusion bypass 
Segmental mural hyperenhancement
• asymemetric
• stratified – bilaminar or trilaminar
• homogeneous, symmetric
Wall thickening
• mild – 3 -5 MM
• moderate –>5–9 MM
• severe - >10 mm
Stricture
• probable stricture without upstream dilation (< 3 cm)
• stricture with mild upstream dilation (3–4 cm)
• stricture with moderate to severe upstream dilation (> 4 cm)
Table 3. 
Radiological findings in CT or MR enterography in Crohn disease.
Crohn’s disease is a panintestinal disease, with intermittent activity and the potential of focal exacerbations 
throughout the patient’s life
It is impossible to cure Crohn’s disease by excision. The surgeon is required only to treat the complications
The essence of surgical treatment is to make the operation as safeas possible. If the operation becomes safe 
and patients survive, they will inevitably have recurrences and so repeated operations may be required.
Therefore, it is important to conserve as much gut as possible All diseased bowels need not be excised, only 
that part with complications
If only stenotic complications are being treated, perhaps the stenosis can be simply widened by 
strictureplasty or dilatation
Table 4. 
Five “Golden Rules” of surgical management of Crohn’s disease.
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is used when you cannot remove the affected segment because adherences to the 
retroperitoneum (Figure 7).
3.1.3 Strictureplasty
Strictureplasty is indicated to prevent small bowel syndrome in those patients 
after repeated resections or extensive bowel resections. Strictures are identified 
by palpation of the small bowel or alternatively introducing a 20 mm ball into the 
Figure 7. 
Bypass surgery: simples bypass (A) and exclusion bypass (B).
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intestine and locating those points where the ball stops. The type of surgery is 
chosen according to the size of stricture (Table 5). The most used techniques are 
Heineke-Mikulicz 81%, Finney 10%, side-to-side isoperistaltic 5%, others 4%. The 
segments more affected are jejunum and/or ileum (94%), previous ileocolonic or 
ileorectal anastomosis (IRA) (4%), duodenum (1%), and colon (1%) [29, 30].
Strictureplasty should be used in those patients with concern for development of 
short bowel syndrome [31, 32].
• Diffuse involvement of the small bowel with multiple strictures.
• Non phlegmonous fibrotic stricture.
• Rapid recurrence of Crohn’s disease manifested as obstruction.
• Stricture(s) in a patient who had undergone previous major resection(s) of 
small bowel (>100 cm).
• Stricture in a patient with intestinal failure or short bowel syndrome.
Strictureplasty has some contraindications [29, 32]:
• Colonic strictures.
• Free or contained perforation of the small bowel.
• Hypoalbuminemia (<2.0 g/dL).
• Multiple strictures within a short segment.
• Phlegmonous inflammation involving the affected site.
• Stricture in close proximity to a site chosen for resection.
4. Short-lenght stricture
The technique of Heineke-Mikulicz [33, 34] (Figure 8) is the most used one and 
is similar to that used for pyloroplasty. A small incision over the stricture is extended 
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Figure 8. 
The Heineke-Mikulicz technique. A - Longitudinal incision; B - transverse suture; C - final aspect.
Figure 9. 
The Moskel-Walske-Neumayer technique. A-Stenosis between segments with different diameters; B - It is made 
an Y shape incision; C - A free-tension suture is made.
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to 2 cm in normal tissue. The incision is closed transversally: 1 or 2 layers with 
absorbable suture and continuous or separate stitch. The Moskel-Walske-Neumayer 
technique (Figure 9) is used when you have a great difference in the width of bowel 
to anastomosis. If you have a fistula in the stricture the Judd (Figure 10) technique is 
preferable to remove the fistula tract and repair the stenosis.
5. Medium-length stricture
The Jaboulay technique requires 2 incisions in normal segments avoiding the 
center of the stenosis (Figure 11).
The Finney technique (Figure 11) consist in one incision along the stenosis reach-
ing up the normal tissue and them the bowel is folded in a U shape to be closed.
Figure 10. 
The Judd technique. A- stenosis with fistula; B - the fistula is removed; C - end-to-end anastomosis.
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6. Long-length stricture
In the Michelassi technique [35] the stenotic segment is divided in the middle 
and a longitudinal incision is made in both segments. A restoring anastomosis is 
Figure 11. 
The Jaboulay technique (1): two incisions in normal segments. A1 - the diseased segment is escluded fron 
the incision; B1 - Posterior and C1 - anterior sutures are made. The Finney technique (2): A2- one incision 
including the deseased segment is made; B2 and C2 show the posterior and anterior sutures.
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made with the overlapping of both diseased segments (Figure 12). The Sasaki 
technique is a modification of Michelassi technique with the use of nonspatulated 
bowel ends to create an additional Heineke-Mikulicz strictureplasty on both ends 
[36] (Figure 12).
The Poggioli technique [37] is a modification of Michelassi technique and the 
difference is that we overlap a diseased segment with a non-diseased segment 
(Figure 13).
A combination of resection and enterostomy was described by Hotokezaka 
[38] (Figure 14). The bowel segment with severe stenosis is removed. The remain-
ing segment with stenosis is divide in the midpoint. A side-to-side antimesenteric 
Figure 12. 
The Michelassi technique (1): A1 - anastomosis of two stenotic segments B1 - the edges of bowel can be trimmed 
to allow better approximation; C1 - latero-lateral anastomosis; D1- final aspect. The variation is the Sasaki 
technique (2): A2 - anastomosis of two diseased segments; B2 - the edges of bowels are mantained; C2 - the end 
of the anastomosis is then transversely closed; D2 - final aspect.
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enterostomy with the 2 bowel segments are made and them and end-to-end 
anastomosis are made between the strictureplasty and the  resection site.
Results Strictureplasty vs. Resection.
The rate of complication for strictureplasty is about 4% to abscess, fistula and 
leakage [31]. Bowel resection is associated with lower recurrence rate (25.1%) 
compared to structureplasty (35.9%; p = 0.04). Recurrence-free survival was longer 
for bowel resection vs. strictureplasty (p = 0.02) [39, 40].
Surgical recurrence was higher for bowel resection (29.4%) vs. stricture-
plasty (39.7%; p = 0.002). No difference was observed for medical recurrence 
for bowel resection (12.4%) vs. strictureplasty (18.0%; p = 0.82) and also for 
overall morbidity between bowel resection (18.1%) vs. strictureplasty (10.7%; 
p = 0.65) [39, 40].
In fact, most cases a combination of techniques are used: resection for the severe 
lesion and plasty for the other. This approach seems to have the same rate of com-
plications. This approach may decrease the risk of intestinal failure because patients 
may need future interventions and additional resection. Young age may be a risk for 
recurrent stricture. The 5-year reoperation rate for recurrent obstruction was 22% 
Figure 13. 
The Poggioli technique. A - long diseased segment; B - the diseased segment is separated from normal segment; 
C - a longitudinal incision is made in both segments; D - lateral enterostomy with overlap of affected and 
normal segments.
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for resection alone, 30% for strictureplasty alone and 42% for strictureplasty and 
resection (P = 0.038) [39, 40].
7. Kono-S anastomosis
Kono et al. [41] reported a new technique of anchored anastomosis that could 
prevent recurrence. After resection of a severe stenosis with linear staple both end 
are put together with suture and a Jaboulay like side-to-side anastomosis is per-
formed [42] (Figure 15).
Figure 14. 
The Hotokezaka technique. A - cecum and terminal ilium are resectes; B - a less affected segment is used to 
strictureplasty; C - Diseased segment is divide at the midle; D - side-to-side antimesenteric enterostomy with 
the 2 bowel segments is made; E - final aspect.
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8. Fecal diversion
The use of fecal diversion is not common but in some clinical conditions may be 
indicated [31]:
• long-term and/or high-dose steroid use,
• recent use of biologics,
• malnutrition with hypoalbumenia (<2 g/dL).
9. Colonic disease
Colonic Crohn disease may be treated by segmental or total colectomy with ileo-
rectal anastomosis. Total proctocolectomy with definitive ileostomy are indicated 
in those patients with severe perineal disease. Ileal pouch–anal anastomosis is less 
indicated due to pouch complications.
Strictureplasty should not be used in large bowel because the risk of maligniza-
tion. Chronic inflammation is a risk factor for colon cancer and dysplasia is consid-
ered to be the precursor of most colorectal cancer in IBD patients [43].
Figure 15. 
Kono-S anastomosis: A - stenosis is removed; B - the ends of both segments are closed; C - both ends are 
put send-to-end; D - longitudinal incisions are made in both segments; E - the suture column beside the 
laterallateral anastomosis may sustain the lumen open and prevent stenosis; F - final aspect.
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10. Duodenal Crohn disease
Due to its anatomical characteristics duodenal stricture may require different 
therapeutic alternatives: endoscopic dilatation, bypass, resection or strictureplasty. 
The incidence of duodenal or upper gastrointestinal tract by Crohn disease varies 
according to age: adults 0.3 to 5%, adolescents 28% and 43% in pediatric patients 
with CD [44]. Patients with duodenal CD may present more aggressive evolution 
with high rates of recurrence and needs for surgical treatments [45].
Clinically patient complain: Epigastric pain, nausea, anorexia, early satiety, bla-
tion and belching, weight, Less common symptoms are: anemia, diarrhea, feculent 
vominiting, hematemesis or melena [46].
Surgical treatment indication: outlet obstruction (83%), refractory pain (11%), 
and bleeding (5%) [47]. Surgical options are: resection, gastrojejunostomy, duo-
deno- jejunostomy, gastroduodenostomy and by-pass.
11. Ulcerative Colitis
Ulcerative colitis (UC) is a chronic inflammatory condition of the colon and 
rectum. Initial therapeutic approach is based in different classes of medicine: anti-
inflammatory, immunosuppressant (aminosalicylates, corticosteroids, thiopurines) 
and biological treatment as anti-tumor necrosis factor (anti-TNF), anti-integrins, 
anti-jak and other. However, most patients have successful clinical control and good 
evolution approximately 20–30% of patients will require surgery during their life [48].
However, surgery is a curative treatment for UC, the decision about an elective 
surgery is preference-sensitive. Generally, the indications for surgery are: medically 
refractory disease, dysplasia and carcinoma.
The surgery basically is total proctocolectomy with anastomosis or end ileostomy. 
The proctocolectomy with anastomosis is the ileal pouch–anal anastomosis (IPAA).
Total abdominal colectomy with ileorectal anastomosis is not indicated to 
patients with UC. The reasons are: half of patients will have a worsen disease in the 
rectum that will need protectomy and the risk of rectal cancer is 7–8% [49].
Proctocolectomy and ileal pouch–anal anastomosis (IPAA)
IPAA procedure may be done in stages:
• Three-stage operation: (1) total colectomy with end ileostomy and rectal stump, 
(2) proctectomy with IPAA and loop ileostomy, and (3) ileostomy closure;
• Two-stage operation: (1) total proctocolectomy with IPAA and loop ileostomy 
and (2) ileostomy tclosure;
• One-stage operation: total proctocolectomy with IPAA and no diversion.
There are different types of pouch and most surgeons favor the J pouch due 
to the simplicity to construct and good outcomes. The procedure may be done by 
laparotomy, laparoscopy, robotic or associated approaches.
12. Continent ileostomy or Kock pouch
It is indicated for those patients who does not meet the criteria for IPAA. It is 
contraindicated in obese patients. The patient has to be able to handle the ostomy 
and do self-intubation.
17
Current Elective Surgical Treatment of Inflammatory Bowel Disease
DOI: http://dx.doi.org/10.5772/intechopen.100112
Author details
Enio Chaves Oliveira1,2,3*, Mauro Bafutto4,5,6, Alexandre Augusto Ferreira Bafutto6, 
Salustiano Gabriel Neto1,8 and Jarbas Jabur Bittar Neto7,8
1 Surgery Department, School of Medicine, Universidade Federal de Goiás, 
Goiânia, Brazil
2 Digestive Unit, Hospital das Clínicas, Universidade Federal de Goiás, Goiânia, 
Brazil
3 Brazilian College of Surgeons, Brazilian College of Digestive Surgery and Brazilian 
Society of Coloproctology, Brazil
4 Gastroenterology, Internal Medicine Department, School of Medicine, 
Universidade Federal de Goiás, Goiânia, Brazil
5 Federação Brasileira de Gastroenterologia, Brazil
6 Instituto Goiano de Gastroenterologia e Endoscopia Digestiva, Goiânia, Brazil
7 Hospital do Coração de Goiás, Goiânia, Brazil
8 Brazilian College of Surgeons, Brazilian College of Digestive Surgery, Brazil
*Address all correspondence to: eco1.br@gmail.com
13. Conclusion
Surgery for bowel Crohn disease is not curative and procedures hat to be as less 
aggressive as possible. Surgery is indicated only in those cases with complication as 
obstruction and fistula. Resection approach is preferable to patients without risk 
to develop short bowel syndrome. Strictureplasty may be used to preserve bowel 
integrity. Different techniques are used depend upon the length of the stenosis. Bowel 
Resection is associated with lower recurrence rate and longer recurrence-free survival.
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